# Osimertinib for Patients With Non–Small-Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Multicenter, Open-Label, Phase II Trial (KCSG-LU15-09)

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/osimertinib-for-patients-with-non-small-cell-lung-cancer-harboring-uncommon-egfr/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Jang Ho Cho,Sung Hee Lim,Ho Jung An,Ki Hwan Kim,Keon Uk Park,Eun Joo Kang,Yoon Hee Choi,Mi Sun Ahn,Myung Hee Lee,Jong‐Mu Sun,Se‐Hoon Lee,Jin Seok Ahn,Keunchil Park,Myung‐Ju Ahn |
| Citations | 363 |
| DOI | 10.1200/jco.19.00931 |
| Fields | Medicine |
| Open Access | true |
| OA Status | green |
| OA URL | https://www.ncbi.nlm.nih.gov/pmc/articles/7098834 |
| OpenAlex ID | https://openalex.org/W2995864319 |
| PMID | 31825714 |
| Type | article |
| Year | 2019 |

## Paper authors

- [Keunchil Park](https://scholariq.org/researchers/keunchil-park/)
- [Se‐Hoon Lee](https://scholariq.org/researchers/se-hoon-lee/)
- [Jin Seok Ahn](https://scholariq.org/researchers/jin-seok-ahn/)
- [Myung‐Ju Ahn](https://scholariq.org/researchers/myung-ju-ahn/)

## Paper journal

- [Journal of Clinical Oncology](https://scholariq.org/journals/journal-of-clinical-oncology/)

## Paper primary topic

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)

## Paper topics

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)
- [Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis](https://scholariq.org/topics/interstitial-lung-diseases-and-idiopathic-pulmonary-fibrosis/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.